Cited by 133Tuberculosis Research and EpidemiologyImmune Response and InflammationMycobacterium research and diagnosis

The DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index.

Lipocalin 2-Dependent Inhibition of Mycobacterial Growth in Alveolar Epithelium

Open access

Abstract

Mycobacterium tuberculosis invades alveolar epithelial cells as well as macrophages. However, the role of alveolar epithelial cells in the host defense against M. tuberculosis remains unknown. In this study, we report that lipocalin 2 (Lcn2)-dependent inhibition of mycobacterial growth within epithelial cells is required for anti-mycobacterial innate immune responses. Lcn2 is secreted into the alveolar space by alveolar macrophages and epithelial cells during the early phase of respiratory mycobacterial infection. Lcn2 inhibits the in vitro growth of mycobacteria through sequestration of iron uptake. Lcn2-deficient mice are highly susceptible to intratracheal infection with M. tuberculosis. Histological analyses at the early phase of mycobacterial infection in Lcn2-deficient mice reveal increased numbers of mycobacteria in epithelial cell layers, but not in macrophages, in the lungs. Increased intracellular mycobacterial growth is observed in alveolar epithelial cells, but not in alveolar macrophages, from Lcn2-deficient mice. The inhibitory action of Lcn2 is blocked by the addition of endocytosis inhibitors, suggesting that internalization of Lcn2 into the epithelial cells is a prerequisite for the inhibition of intracellular mycobacterial growth. Taken together, these findings highlight a pivotal role for alveolar epithelial cells during mycobacterial infection, in which Lcn2 mediates anti-mycobacterial innate immune responses within the epithelial cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.181.12.8521

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 44 references

2 of the 44 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

  1. 2004, Immunity to tuberculosis, 599
  2. 1997, Uterocalin: a mouse acute phase protein expressed in the uterus around birth, 507
  3. 2000, Generation of an immortal differentiated lung type-II epithelial cell line from the adult H-2K(b)tsA58 transgenic mouse, 374

Cited by

Sorted by citations

Items 101–133 of 133

Metadata

Authors
Saiga, H., Nishimura, J., Kuwata, H., Okuyama, M., Matsumoto, S., Sato, S., Matsumoto, M., Akira, S., Yoshikai, Y., Honda, K., Yamamoto, M., & Takeda, K.
Affiliations
  • The University of Osaka (JP)
  • Department of Molecular Genetics
  • Osaka City University (JP)
  • Research Institute for Microbial Diseases, The University of Osaka (JP)
  • Immunology Frontier Research Center, The University of Osaka (JP)
  • Kyushu University (JP)
Venue
The Journal of Immunology
Published
2008-12
Volume
181
Issue
12
Pages
8521-8527
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W1898659608
Cited by
133
References
44
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2023: 6 · 2022: 7 · 2021: 6 · 2020: 2 · 2019: 5 · 2018: 6 · 2017: 7 · 2016: 6 · 2015: 10 · 2014: 11 · 2013: 13 · 2012: 19
FWCI
6.01
Type
journal article
Language
en
Open access
Locations
  • The Journal of Immunology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Ministry of Education, Culture, Sports, Science and Technology
Topics
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
Keywords
neutrophil gelatinase-associated lipocalin, Mycobacterium tuberculosis, alveolar epithelial cells, innate immunity, iron sequestration, endocytosis, pulmonary tuberculosis, alveolar macrophages
MeSH terms
Lipocalin-2, Acute-Phase Proteins, Animals, Cell Line, Mice, Inbred C57BL, Mice, Transgenic, Mycobacterium bovis, Mycobacterium tuberculosis, Pulmonary Alveoli, Tuberculosis, Oncogene Proteins, Macrophages, Alveolar, Mice, Knockout, Respiratory Mucosa, Mice, Lipocalins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review